Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
IBUY | 56.79% | $153.92M | 0.65% |
FFTY | 54.81% | $64.06M | 0.8% |
PTH | 54.17% | $110.42M | 0.6% |
ARKK | 52.57% | $5.08B | 0.75% |
BUZZ | 52.00% | $48.16M | 0.76% |
ARKQ | 51.35% | $828.61M | 0.75% |
KOMP | 50.63% | $1.95B | 0.2% |
ARKX | 50.53% | $260.94M | 0.75% |
IWO | 50.33% | $10.88B | 0.24% |
ARKG | 50.08% | $977.87M | 0.75% |
FNY | 50.06% | $370.72M | 0.7% |
ARKF | 48.63% | $884.14M | 0.75% |
VBK | 48.18% | $17.51B | 0.07% |
CWB | 48.17% | $3.84B | 0.4% |
BKCH | 46.82% | $116.08M | 0.5% |
VXF | 46.78% | $20.19B | 0.05% |
ISCG | 46.60% | $654.50M | 0.06% |
ICVT | 46.46% | $2.56B | 0.2% |
XSW | 46.41% | $464.74M | 0.35% |
ITEQ | 46.41% | $86.43M | 0.75% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -43.42% | $404.97M | 1.43% |
TAIL | -26.12% | $86.92M | 0.59% |
VIXY | -24.57% | $195.31M | 0.85% |
CCOR | -14.43% | $64.35M | 1.18% |
TBIL | -13.74% | $5.32B | 0.15% |
XBIL | -11.15% | $708.45M | 0.15% |
XHLF | -10.64% | $1.06B | 0.03% |
SGOV | -9.39% | $39.39B | 0.09% |
IYK | -9.25% | $1.50B | 0.4% |
USFR | -8.93% | $18.41B | 0.15% |
GBIL | -8.43% | $6.31B | 0.12% |
TPMN | -8.42% | $33.51M | 0.65% |
TBLL | -8.34% | $2.07B | 0.08% |
TFLO | -8.05% | $6.78B | 0.15% |
UUP | -7.91% | $327.80M | 0.77% |
USDU | -7.42% | $213.46M | 0.5% |
IBTF | -6.70% | $2.24B | 0.07% |
FTXG | -6.65% | $25.74M | 0.6% |
BILS | -6.60% | $3.66B | 0.1356% |
BIL | -6.59% | $41.08B | 0.1356% |
Yahoo
Questions about insurance coverage for weight-loss drugs are getting more intense as cheaper alternatives go off the market.
Yahoo
Hims & Hers Health said it is expanding its weight-loss offerings with the addition of Eli Lilly & Co. Zepbound and generic liraglutide. The telehealth-consultation platform on Tuesday said it aimed to bring its customers more treatment options to best suit their needs. “We’ve now expanded that choice even further by adding access to generic liraglutide and branded tirzepatide through our platform,” the company said.
Yahoo
Yahoo Finance Senior Reporter Anjalee Khemlani joins Market Domination to discuss some of the top stories of the trading day, including Johnson & Johnson's (JNJ) setback in its litigation. Additionally, Hims & Hers (HIMS) expanded its offerings, adding Eli Lilly's (LLY) GLP-1 drugs to its telehealth platform, following its earlier partnership with Novo Nordisk. To watch more expert insights and analysis on the latest market action, check out more Market Domination here.
Yahoo
Hims stock surged Tuesday after the compounding pharmacy said it would sell Eli Lilly's branded weight-loss drug on its telehealth platform.
Yahoo
Hims stock surged Tuesday after the compounding pharmacy said it would sell Eli Lilly's branded weight-loss drug on its telehealth platform.
Yahoo
It is hard to get excited after looking at Hims & Hers Health's (NYSE:HIMS) recent performance, when its stock has...
Double maintains 4 strategies that include HIMS - Hims & Hers Health, Inc.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
DUK | -19.54% | $94.77B | +26.96% | 3.42% |
AEP | -19.45% | $58.35B | +29.22% | 3.34% |
PEP | -18.47% | $205.64B | -13.32% | 3.60% |
CL | -17.99% | $76.00B | +5.21% | 2.12% |
CAG | -17.40% | $12.73B | -10.14% | 5.23% |
WST | -17.04% | $16.18B | -43.46% | 0.37% |
CBOE | -15.61% | $23.69B | +24.42% | 1.08% |
JKHY | -15.29% | $13.31B | +7.12% | 1.21% |
TSN | -15.26% | $22.28B | +10.30% | 3.10% |
AWK | -15.06% | $28.76B | +22.63% | 2.08% |
ED | -14.90% | $39.05B | +22.43% | 3.04% |
GIS | -14.53% | $32.74B | -14.74% | 3.99% |
PG | -14.39% | $399.61B | +6.13% | 2.36% |
MKTX | -14.03% | $8.15B | -0.10% | 1.38% |
ADM | -12.79% | $23.05B | -23.00% | 4.19% |
MDLZ | -12.75% | $87.77B | -2.74% | 2.69% |
NEE | -12.64% | $145.82B | +11.85% | 2.97% |
NOC | -12.33% | $74.12B | +8.63% | 1.60% |
KO | -11.74% | $308.22B | +18.03% | 2.74% |
CPB | -11.51% | $11.90B | -10.61% | 3.74% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
RXRX | 47.63% | $2.13B | -43.54% | 0.00% |
HOOD | 46.42% | $36.85B | +114.43% | 0.00% |
AEIS | 44.88% | $3.60B | -5.95% | 0.42% |
RIOT | 43.17% | $2.49B | -37.93% | 0.00% |
XYZ | 42.93% | $33.66B | -33.30% | 0.00% |
CLSK | 42.14% | $1.89B | -63.83% | 0.00% |
COIN | 41.34% | $43.73B | -31.68% | 0.00% |
RKLB | 40.16% | $8.11B | +338.24% | 0.00% |
MARA | 40.11% | $3.98B | -46.83% | 0.00% |
TDOC | 39.62% | $1.38B | -46.40% | 0.00% |
CRSR | 39.43% | $929.02M | -27.44% | 0.00% |
WSC | 39.43% | $5.10B | -37.03% | 0.25% |
CRSP | 39.39% | $2.92B | -50.09% | 0.00% |
BTBT | 39.19% | $368.52M | -26.81% | 0.00% |
DDD | 39.05% | $287.34M | -50.70% | 0.00% |
MGM | 38.89% | $8.46B | -37.97% | 0.00% |
RDW | 38.48% | $626.50M | +89.70% | 0.00% |
GKOS | 38.11% | $5.57B | +5.71% | 0.00% |
PGY | 38.04% | $789.13M | +10.78% | 0.00% |
KODK | 37.94% | $509.39M | +30.31% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CSAN | 0.07% | $2.44B | -58.24% | 6.19% |
SPTN | -0.08% | $684.07M | +2.07% | 4.31% |
GXO | 0.09% | $4.67B | -25.75% | 0.00% |
ALE | 0.10% | $3.81B | +10.18% | 4.34% |
CHRW | 0.12% | $12.11B | +39.62% | 2.41% |
BBD | 0.15% | $11.80B | -15.11% | 1.80% |
GERN | -0.15% | $1.01B | -49.84% | 0.00% |
NOVA | -0.15% | $46.53M | -93.44% | 0.00% |
ETR | -0.17% | $36.83B | +63.24% | 4.75% |
BBVA | 0.17% | $78.41B | +16.01% | 5.37% |
PARAA | 0.18% | $15.26B | +7.21% | 0.88% |
IMNN | 0.19% | $15.35M | -45.60% | 0.00% |
MKL | -0.19% | $23.87B | +23.92% | 0.00% |
BAX | -0.20% | $17.56B | -21.40% | 2.69% |
AEE | 0.20% | $27.12B | +37.08% | 2.72% |
ABT | 0.22% | $230.06B | +18.34% | 1.69% |
VOD | -0.28% | $23.40B | +6.60% | 7.71% |
THG | 0.30% | $6.25B | +29.90% | 2.00% |
LFVN | -0.31% | $183.00M | +128.17% | 1.05% |
TIGO | -0.32% | $5.21B | +50.82% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
CGSD | 0.01% | $1.09B | 0.25% |
USTB | 0.06% | $1.14B | 0.35% |
TOTL | 0.07% | $3.50B | 0.55% |
GOVZ | 0.11% | $288.61M | 0.1% |
IBDQ | 0.12% | $3.18B | 0.1% |
ZROZ | 0.13% | $1.57B | 0.15% |
BSMR | -0.20% | $232.31M | 0.18% |
AGGH | -0.28% | $313.78M | 0.29% |
PULS | -0.30% | $10.97B | 0.15% |
GNMA | -0.31% | $355.19M | 0.1% |
ULST | -0.32% | $587.03M | 0.2% |
MINT | -0.40% | $13.27B | 0.35% |
BSV | 0.46% | $34.52B | 0.03% |
AGZD | -0.47% | $136.29M | 0.23% |
LGOV | 0.47% | $658.58M | 0.67% |
OWNS | -0.49% | $134.66M | 0.3% |
TLTW | 0.52% | $1.15B | 0.35% |
CGSM | 0.58% | $636.53M | 0.25% |
UCON | 0.60% | $3.46B | 0.85% |
GSST | -0.60% | $799.64M | 0.16% |
Current Value
$29.701 Year Return
Current Value
$29.701 Year Return